Connect Biopharma Holdings Limited
CNTB
$1.03
$0.02992.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -36.50M | -55.56M |
| Total Depreciation and Amortization | -- | -- | -- | 615.00K | 630.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 5.19M | 4.66M |
| Change in Net Operating Assets | -- | -- | -- | 9.53M | 17.52M |
| Cash from Operations | -- | -- | -- | -21.16M | -32.75M |
| Capital Expenditure | -- | -- | -- | -10.00K | 63.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 2.00K | 2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 56.29M | 67.12M |
| Cash from Investing | -- | -- | -- | 56.28M | 67.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 70.00K | 72.00K |
| Issuance of Common Stock | -- | -- | -- | 74.00K | 34.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 144.00K | 106.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -622.00K | -683.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 34.64M | 33.85M |